Covered recipient · General Payments record
SCOTT A MAZUREK
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2022–2023
$781.30
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $755.42 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $246.79 | 2 |
| Amryt Pharma Holdings Ltd | $147.49 | 2 |
| BETA BIONICS, INC. | $137.86 | 1 |
| DEXCOM, INC. | $109.94 | 2 |
| Horizon Pharma plc | $98.28 | 1 |
| Lilly USA, LLC | $15.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amryt Pharma Holdings Ltd | $15.48 | 07/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051604233 | CMS |
| Amryt Pharma Holdings Ltd | $132.01 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051604423 | CMS |
| BETA BIONICS, INC. | $137.86 | 09/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060384035 | CMS |
| Dexcom, Inc. | $85.34 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054794559 | CMS |
| Dexcom, Inc. | $24.60 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054794547 | CMS |
| Horizon Therapeutics plc | $98.28 | 11/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987044283 | CMS |
| Lilly USA, LLC | $15.06 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032298743 | CMS |
| Medtronic, Inc. | $128.73 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019662651 | CMS |
| Medtronic, Inc. | $118.06 | 10/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019662659 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.